JP2020531514A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020531514A5 JP2020531514A5 JP2020511214A JP2020511214A JP2020531514A5 JP 2020531514 A5 JP2020531514 A5 JP 2020531514A5 JP 2020511214 A JP2020511214 A JP 2020511214A JP 2020511214 A JP2020511214 A JP 2020511214A JP 2020531514 A5 JP2020531514 A5 JP 2020531514A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- rage
- modulator according
- modulator
- cytoplasmic tail
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023121818A JP7855180B2 (ja) | 2017-08-22 | 2023-07-26 | 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節 |
| JP2025227130A JP2026062654A (ja) | 2017-08-22 | 2025-12-03 | 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017903381A AU2017903381A0 (en) | 2017-08-22 | Screening Assays, Modulators and Modulation of Activation of Receptor For Advanced Glycation End-Products (RAGE) | |
| AU2017903381 | 2017-08-22 | ||
| AU2018902298A AU2018902298A0 (en) | 2018-06-26 | Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE) | |
| AU2018902298 | 2018-06-26 | ||
| PCT/AU2018/050883 WO2019036753A1 (en) | 2017-08-22 | 2018-08-21 | SCREENING TESTS, MODULATORS AND MODULATION OF RECEIVER ACTIVATION FOR ADVANCED GLYCATION TERMINAL PRODUCTS (RAGE) |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023121818A Division JP7855180B2 (ja) | 2017-08-22 | 2023-07-26 | 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節 |
| JP2025227130A Division JP2026062654A (ja) | 2017-08-22 | 2025-12-03 | 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020531514A JP2020531514A (ja) | 2020-11-05 |
| JP2020531514A5 true JP2020531514A5 (cg-RX-API-DMAC7.html) | 2021-09-30 |
| JP7865475B2 JP7865475B2 (ja) | 2026-05-26 |
Family
ID=65438276
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511214A Active JP7865475B2 (ja) | 2017-08-22 | 2018-08-21 | 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節 |
| JP2023121818A Active JP7855180B2 (ja) | 2017-08-22 | 2023-07-26 | 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節 |
| JP2025227130A Pending JP2026062654A (ja) | 2017-08-22 | 2025-12-03 | 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023121818A Active JP7855180B2 (ja) | 2017-08-22 | 2023-07-26 | 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節 |
| JP2025227130A Pending JP2026062654A (ja) | 2017-08-22 | 2025-12-03 | 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12060408B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3672982B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7865475B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN120607606A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018322482B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3109871A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019036753A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3109871A1 (en) * | 2017-08-22 | 2019-02-28 | Monash University | Screening assays, modulators and modulation of activation of receptor for advanced glycation end-products (rage) |
| KR102203850B1 (ko) * | 2019-04-09 | 2021-01-18 | 사회복지법인 삼성생명공익재단 | 신경교종의 진단 또는 예후 예측용 조성물 및 이에 관한 정보를 제공하는 방법 |
| EP4168548A1 (en) | 2020-06-22 | 2023-04-26 | Regeneron Pharmaceuticals, Inc. | Treatment of obesity with g-protein coupled receptor 75 (gpr75) inhibitors |
| WO2022150709A1 (en) * | 2021-01-11 | 2022-07-14 | President And Fellows Of Harvard College | Compositions and methods for treating viral infection |
| CN113293212A (zh) * | 2021-06-17 | 2021-08-24 | 深圳华因康基因科技有限公司 | 一种检测神经母细胞瘤复发转移基因fzd2扩增的引物探针及其应用 |
| CN113789379B (zh) * | 2021-08-30 | 2022-08-23 | 远见生物科技(上海)有限公司 | 一种检测前列腺癌的诊断试剂盒及其检测方法与应用 |
| JP2023084477A (ja) * | 2021-12-07 | 2023-06-19 | 花王株式会社 | 硫黄化合物を原因とするにおいの抑制剤の評価及び/又は選択方法 |
| WO2023140700A1 (ko) | 2022-01-24 | 2023-07-27 | 서울대학교산학협력단 | 장 미각 수용체 tas1r3 발현 및 활성화 억제를 통한 서구식 식이 유발 염증성 장 질환의 예방 또는 치료 |
| WO2023164290A2 (en) * | 2022-02-28 | 2023-08-31 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and compositions for treating cancers and other proliferative disorders |
| KR20230147988A (ko) * | 2022-04-15 | 2023-10-24 | 아주대학교산학협력단 | Rage 길항제 및 age 소거제를 포함하는 당뇨성 뇌졸중 예방 또는 치료용 약학적 조성물 |
| WO2024044659A1 (en) * | 2022-08-24 | 2024-02-29 | Tectonic Therapeutic, Inc. | Constitutively active g protein-coupled receptor compositions and methods of use thereof |
| CN115798616B (zh) * | 2022-10-26 | 2026-06-19 | 大连大学 | 基于dna链置换的新型生物分子控制器的实现方法 |
| CN118777620A (zh) * | 2023-04-07 | 2024-10-15 | 浙江友宁生物医药科技有限公司 | Gpr139受体激活检测方法、生理功能评价方法及应用 |
| CN116410335B (zh) * | 2023-04-24 | 2024-08-13 | 徐州医科大学 | 一种多肽tat-mrgprx1c及其应用 |
| CN118755834B (zh) * | 2024-07-15 | 2025-11-18 | 河北医科大学第四医院(河北省肿瘤医院) | 胃癌复发预测模型 |
| CN119901926A (zh) * | 2025-03-31 | 2025-04-29 | 浙江省立同德医院(浙江省精神卫生研究院) | 一种基于rage过表达和spr技术的rage靶向药物筛选方法 |
| CN121695261B (zh) * | 2026-02-11 | 2026-04-17 | 湖南启元生物科技有限公司 | 一种蛋白组合物及其制备方法 |
| CN121774990A (zh) * | 2026-03-05 | 2026-04-03 | 浙江省中医院、浙江中医药大学附属第一医院(浙江省东方医院) | 七叶皂苷钠在制备防治糖尿病视网膜病变药物中的应用 |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US5004687A (en) | 1985-05-21 | 1991-04-02 | University Of Georgia Research Foundation, Inc. | Insect virus vector with broadened host range |
| US4868103A (en) | 1986-02-19 | 1989-09-19 | Enzo Biochem, Inc. | Analyte detection by means of energy transfer |
| US5273876A (en) | 1987-06-26 | 1993-12-28 | Syntro Corporation | Recombinant human cytomegalovirus containing foreign gene |
| CA2045129A1 (en) | 1989-02-01 | 1990-08-02 | Alfred I. Geller | Herpes simplex virus type i expression vector |
| GB8923123D0 (en) | 1989-10-13 | 1989-11-29 | Connaught Lab | A vaccine for human immunodeficiency virus |
| EP0549723A1 (en) | 1990-09-21 | 1993-07-07 | Chiron Corporation | Packaging cells |
| ATE188740T1 (de) | 1991-02-19 | 2000-01-15 | Univ California | Viruspartikel mit veraendertem wirtspektrum |
| GB9105383D0 (en) | 1991-03-14 | 1991-05-01 | Immunology Ltd | An immunotherapeutic for cervical cancer |
| US6013638A (en) | 1991-10-02 | 2000-01-11 | The United States Of America As Represented By The Department Of Health And Human Services | Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung |
| EP0552108B1 (en) | 1992-01-17 | 1999-11-10 | Lakowicz, Joseph R. | Energy transfer phase-modulation fluoro-immunoassay |
| AU3972893A (en) | 1992-04-03 | 1993-11-08 | Baylor College Of Medicine | Gene therapy using the intestine |
| US6130074A (en) | 1992-06-01 | 2000-10-10 | American Cyanamid Company Five Giralda Farms | Recombinant insect virus with reduced capacity for host-to-host transmission in the environment and methods to produce said virus |
| SE9201984D0 (sv) | 1992-06-29 | 1992-06-29 | Pharmacia Biosensor Ab | Improvement in optical assays |
| JP3147514B2 (ja) | 1992-07-08 | 2001-03-19 | 住友電装株式会社 | 電線送給装置 |
| AU6014094A (en) | 1992-12-02 | 1994-06-22 | Baylor College Of Medicine | Episomal vectors for gene therapy |
| AU680508B2 (en) | 1993-04-06 | 1997-07-31 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Gibbon ape leukemia virus-based retroviral vectors |
| US6133028A (en) | 1993-05-28 | 2000-10-17 | Transgene S.A. | Defective adenoviruses and corresponding complementation lines |
| US6120764A (en) | 1993-06-24 | 2000-09-19 | Advec, Inc. | Adenoviruses for control of gene expression |
| US6140087A (en) | 1993-06-24 | 2000-10-31 | Advec, Inc. | Adenovirus vectors for gene therapy |
| AU7353494A (en) | 1993-11-12 | 1995-05-29 | Case Western Reserve University | Episomal expression vector for human gene therapy |
| US5731172A (en) | 1994-03-09 | 1998-03-24 | Sumitomo Pharmaceuticals Company, Ltd. | Recombinant adenovirus and process for producing the same |
| US5833993A (en) | 1994-04-29 | 1998-11-10 | Pharmacia & Upjohn Company | Feline immunodeficiency virus vaccine |
| US5604090A (en) | 1994-06-06 | 1997-02-18 | Fred Hutchinson Cancer Research Center | Method for increasing transduction of cells by adeno-associated virus vectors |
| US5662897A (en) | 1994-07-27 | 1997-09-02 | U. Of Ga Research Foundation | Insect viruses, sequences, insecticidal compositions and methods of use |
| US5693508A (en) | 1994-11-08 | 1997-12-02 | Chang; Lung-Ji | Retroviral expression vectors containing MoMLV/CMV-IE/HIV-TAR chimeric long terminal repeats |
| JP3770333B2 (ja) | 1995-03-15 | 2006-04-26 | 大日本住友製薬株式会社 | 組換えdnaウイルスおよびその製造方法 |
| GB9506782D0 (en) | 1995-04-01 | 1995-05-24 | British Biotech Pharm | Retroviral vectors |
| CA2226575C (en) | 1995-07-27 | 2011-10-18 | Genentech, Inc. | Stabile isotonic lyophilized protein formulation |
| JPH11511326A (ja) | 1995-08-30 | 1999-10-05 | ジエンザイム コーポレイション | アデノウィルスおよびaavの精製 |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| US6020192A (en) | 1996-01-18 | 2000-02-01 | University Of Florida | Humanized green fluorescent protein genes and methods |
| US5874304A (en) | 1996-01-18 | 1999-02-23 | University Of Florida Research Foundation, Inc. | Humanized green fluorescent protein genes and methods |
| CA2247091A1 (en) | 1996-03-05 | 1997-09-12 | The Regents Of The University Of California | Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| US5952221A (en) | 1996-03-06 | 1999-09-14 | Avigen, Inc. | Adeno-associated virus vectors comprising a first and second nucleic acid sequence |
| US5891646A (en) | 1997-06-05 | 1999-04-06 | Duke University | Methods of assaying receptor activity and constructs useful in such methods |
| US6156303A (en) | 1997-06-11 | 2000-12-05 | University Of Washington | Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
| US6143565A (en) | 1997-08-22 | 2000-11-07 | The United States Of America As Represented By The Secretary Of Agriculture | Stable insect virus-cell expression system |
| US6893827B1 (en) | 2000-02-07 | 2005-05-17 | Applera Corporation | Receptor function assay for G-protein coupled receptors and orphan receptors by reporter enzyme mutant complementation |
| EP1345968A2 (en) | 2000-12-28 | 2003-09-24 | Altus Biologics Inc. | Crystals of whole antibodies and fragments thereof and methods for making and using them |
| JPWO2003008446A1 (ja) | 2001-07-19 | 2004-11-11 | 三菱ウェルファーマ株式会社 | 後期糖化産物受容体のシグナル伝達に関連するポリペプチド |
| CN1894581B (zh) | 2003-07-09 | 2012-02-01 | 生命技术公司 | 检测蛋白-蛋白相互作用的方法 |
| US7488583B2 (en) | 2003-09-25 | 2009-02-10 | Odyssey Thera, Inc. | Fragment complementation assays for G-protein-coupled receptors and their signaling pathways |
| ES2473587T3 (es) | 2004-08-03 | 2014-07-07 | Transtech Pharma, Inc. | Proteínas de fusión de RAGE y métodos de uso |
| EP1869464A4 (en) | 2005-03-17 | 2009-12-02 | Univ Columbia | RAGE-DIAPHANOUS INTERACTION AND CORRESPONDING COMPOSITIONS AND METHODS |
| JP5295785B2 (ja) | 2006-02-20 | 2013-09-18 | エファ・ユニバーシティ・インダストリー・コラボレイション・ファウンデイション | 細胞膜透過性ペプチド |
| MX2008011933A (es) | 2006-03-21 | 2008-12-18 | Wyeth Corp | Metodos y composiciones para antagonismo de rage. |
| WO2008055314A1 (en) | 2006-11-10 | 2008-05-15 | Dimerix Bioscience Pty Ltd | Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |
| WO2008154638A2 (en) | 2007-06-12 | 2008-12-18 | Board Of Regents, The University Of Texas System | Antagonists of the receptor for advanced glycation end-products (rage) |
| US8101373B2 (en) | 2007-10-12 | 2012-01-24 | Discoverx Corporation | β-galactosidase donor fragments |
| WO2012109569A1 (en) | 2011-02-11 | 2012-08-16 | The Trustees Of Columbia University In The City Of New York | The receptor for advanced glycation endproducts (rage) is a receptor for lysophosphatidic acid (lpa) |
| WO2012159164A1 (en) | 2011-05-23 | 2012-11-29 | Phylogica Limited | Method of determining, identifying or isolating cell-penetrating peptides |
| EP2756005B1 (en) | 2011-09-14 | 2016-03-02 | Abeterno Technologies Limited | Intracellular cell selection |
| CA3109871A1 (en) * | 2017-08-22 | 2019-02-28 | Monash University | Screening assays, modulators and modulation of activation of receptor for advanced glycation end-products (rage) |
-
2018
- 2018-08-21 CA CA3109871A patent/CA3109871A1/en active Pending
- 2018-08-21 JP JP2020511214A patent/JP7865475B2/ja active Active
- 2018-08-21 US US16/641,174 patent/US12060408B2/en active Active
- 2018-08-21 CN CN202411603566.3A patent/CN120607606A/zh active Pending
- 2018-08-21 WO PCT/AU2018/050883 patent/WO2019036753A1/en not_active Ceased
- 2018-08-21 AU AU2018322482A patent/AU2018322482B2/en active Active
- 2018-08-21 EP EP18849151.8A patent/EP3672982B1/en active Active
- 2018-08-21 CN CN201880068213.4A patent/CN111247163B/zh active Active
-
2023
- 2023-07-26 JP JP2023121818A patent/JP7855180B2/ja active Active
-
2024
- 2024-08-13 US US18/802,964 patent/US20250019415A1/en active Pending
-
2025
- 2025-12-03 JP JP2025227130A patent/JP2026062654A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Toro et al. | MaxiK channel and cell signalling | |
| JP7212009B2 (ja) | Cxcr4結合分子 | |
| US8440627B2 (en) | G protein coupled receptor agonists and antagonists and methods of use | |
| EP2970415B1 (en) | Apelin fusion proteins and uses thereof | |
| AU2006212813B2 (en) | Compositions and methods related to soluble G-protein coupled receptors (sGPCRs) | |
| AU2018322482B2 (en) | Screening assays, modulators and modulation of activation of receptor for advanced glycation end-products (RAGE) | |
| Perlman et al. | Hydrogen bonding interaction of thyrotropin-releasing hormone (TRH) with transmembrane tyrosine 106 of the TRH receptor. | |
| CN110225924A (zh) | 松弛素融合多肽及其用途 | |
| Kolakowski et al. | Probing the “Message: Address” Sites for Chemoattractant Binding to the C5a Receptor: MUTAGENESIS OF HYDROPHILIC AND PROLINE RESIDUES WITHIN THE TRANSMEMBRANE SEGMENTS | |
| CN114591415B (zh) | Glp-1/gcg双受体激动剂多肽及其融合蛋白 | |
| Lin et al. | GPS proteolytic cleavage of adhesion-GPCRs | |
| US20110230401A1 (en) | Insulin fusion polypeptides | |
| EP2480568A1 (en) | Polypeptides and nucleic acids for treating erbb2-dependent cancers | |
| Schneider et al. | Histamine H4 receptor–RGS fusion proteins expressed in Sf9 insect cells: A sensitive and reliable approach for the functional characterization of histamine H4 receptor ligands | |
| US20080206231A1 (en) | Compositions and Methods for Treating Disease | |
| Li et al. | Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain | |
| Lallement et al. | Cholecystokinin and gastrin are not equally sensitive to GTPγS at CCKB receptors: importance of the sulphated tyrosine | |
| Tomasovic et al. | Role of Cbl-associated protein/ponsin in receptor tyrosine kinase signaling and cell adhesion | |
| KR102778534B1 (ko) | G 단백질 알파 서브유닛의 알파-헬리컬 도메인의 실시간 구조 변화 확인 방법 및 시스템 | |
| Raingeaud et al. | Production, analysis and bioactivity of recombinant vasoactive intestinal peptide analogs | |
| Rached et al. | Stable expression of human melanocortin 3 receptor fused to EGFP in the HEK293 cells | |
| Kakizawa | Apelin | |
| Won et al. | The GTPase domain of Galphao contributes to the functional interaction of Galphao with the promyelocytic leukemia zinc finger protein | |
| Niimi et al. | Expression of the Long Arm Sequence of Mouse Laminin α1, β1, or γ; l Chain in COSl Cells and Assembly of Monkey-Mouse Hybrid Laminin | |
| US20080160552A1 (en) | Methods and Compounds for Treating Inflammation |